Please wait while the formulary information is being retrieved.
DOUBLE ANTIBIOTIC-PAIN RELIEF (NEOMYCIN SULFATE/POLYMYXIN B SULFATE/PRAMOXINE)
- Minor bacterial skin infections
- Minor skin wound pain
- Neosporin + Pain Relief Topical Cream
- Multi Antibiotic Plus Topical Cream
- Double Antibiotic-pain Relief Topical Cream
- Antibiotic Plus Pain Relief (pramoxine) Topical Cream
- Antibiotic Plus (pramoxine) Top Cream
- Antibiotic + Pain Relief Topical Cream
3.5 mg-10,000 unit-10 mg/gram topical cream
- Dosage information is not available
3.5 mg-10,000 unit-10 mg/gram topical cream
- Dosage information is not available
3.5 mg-10,000 unit-10 mg/gram top cream
- Dosage information is not available
3.5 mg-10,000 unit-10 mg/gram top cream
- Dosage information is not available
(pramoxine) 3.5 mg-10,000 unit-10 mg/gram top cream
- Dosage information is not available
Antibiotic Plus (pramoxine) 3.5 mg-10,000 unit-10 mg/gram top cream
- Dosage information is not available
3.5 mg-10,000 unit-10 mg/gram top cream
- Dosage information is not available
- None
Contraindicated
- None
Severe
Moderate
- None
- None
Contraindicated
- Large open wound
- Severe burns
Severe
Moderate
- Large open wound
- No disease contraindications
DOUBLE ANTIBIOTIC-PAIN RELIEF (NEOMYCIN SULFATE/POLYMYXIN B SULFATE/PRAMOXINE)
- Minor bacterial skin infections
- Minor skin wound pain
- Dermatitis due to topical drug
- Skin rash
- None
More Frequent
Severe
Less Severe
- Angioedema
- Dermatitis due to topical drug
- Erythema
- Pruritus of skin
- Skin rash
- Stinging of skin
- Urticaria
- None
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Acute respiratory insufficiency
- Anaphylaxis
- Bradycardia
- Cardiac arrhythmia
- CNS toxicity
- Cyanosis
- Drowsy
- Eyelid edema
- Headache disorder
- Hypotension
- Methemoglobinemia
- Ototoxicity
- Respiratory depression
- Seizure disorder
- Tremor
- Unconsciousness
Less Severe
- Acute confusion
- Apprehension
- Blurred vision
- Dizziness
- Edema
- Euphoria
- Nervousness
- Sensation of cold
- Sensation of warmth
- Skin rash
- Tinnitus
- Twitching
- Vomiting
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Pramoxine
Pediatrics are more sensitive to toxic effects.
- 1 Day – 12 Years
- Pediatrics are more sensitive to toxic effects.
Neomycin (topical)
- Severity Level:
2
- Additional Notes: Insufficient data available for topical product.
Polymyxin B Sulfate (ophth,otic,top)
- Severity Level:
B
- Additional Notes:
Pramoxine
- Severity Level:
C
- Additional Notes: Insufficient human data
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Neomycin (topical, Ophth)
Insufficient data available
None
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient data available |
Polymyxin B
Insufficient data available
None
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | None |
No Known Risk
Pramoxine
Per briggs, unlikely that significant amounts would be excreted in milk
| General | Excretion Potential | Effect on Infant | Notes |
| No known risks; does not adversely affect lactation | Unknown | Not known; no or inclusive data | Per briggs, unlikely that significant amounts would be excreted in milk |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Minor bacterial skin infections | |
| L08.89 | Other specified local infections of the skin and subcutaneous tissue |
| L08.9 | Local infection of the skin and subcutaneous tissue, unspecified |
| 0-9 | A-Z |
|---|---|
| L08.89 | Other specified local infections of the skin and subcutaneous tissue |
| L08.9 | Local infection of the skin and subcutaneous tissue, unspecified |
Formulary Reference Tool